Yuan-zhi Bie

Publications (2)0 Total impact

• Article: [Clinical analysis of the primary laryngeal inflammatory myofibroblastic tumor].

  Wan-ju LI, Jing-wu SUN, Yuan-zhi BIE
  Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 04/2012; 47(4):338-9.
• Article: [Endoscopic transnasal prelacrimal recess-maxillary sinus approach for tumors in the pterygopalatine fossa].

  Yuan-zhi Bie, Jing-wu Sun, Jia-qiang Sun, Tao Guo
  [show abstract] [hide abstract]
  ABSTRACT: To explore the application of endoscopic transnasal prelacrimal recess-maxillary sinus approach in surgery for lesions in the pterygopalatine fossa. Five patients with tumors of pterygopalatine fossa were treated by endoscopic transnasal prelacrimal recess-maxillary sinus surgery between May 2008 and May 2011. The lesions treated included 4 schwannoma. and 1 neurofibroma. The operation began with endoscopic transnasal lateral nasal wall approach to maxillary sinus. Then after opening posterior wall of maxillary sinus, the pterygopalatine fossa was entered and the tumor was removed. The operation was performed under hypotension anaesthesia. The tumors were removed totally in all 5 patients. No complication was found. After the surgery, all patients fully recovered and were discharged from the hospital in 5 to 12 days. No recurrence and death occurred during the follow up periods ranging from 5 to 28 months. Endoscopic transnasal prelacrimal recess-maxillary sinus approach is safe and effective management for benign tumors in the pterygopalatine fossa. This approach reserved nasolacrimal duct and turbinate, maintained the structure and function of the nose, with decreased morbidity and shorter recovery periods.
  Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 01/2012; 47(1):26-9.